6.
Kanda Y, Ohata H, Miyazaki T, Sakai H, Mori Y, Shiokawa D
. NF-κB suppression synergizes with E7386, an inhibitor of CBP/β-catenin interaction, to block proliferation of patient-derived colon cancer spheroids. Biochem Biophys Res Commun. 2021; 586:93-99.
DOI: 10.1016/j.bbrc.2021.11.063.
View
7.
Zohlnhofer D, Richter T, Neumann F, Nuhrenberg T, Wessely R, Brandl R
. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell. 2001; 7(5):1059-69.
DOI: 10.1016/s1097-2765(01)00239-8.
View
8.
Josipovic I, Pfluger B, Fork C, Vasconez A, Oo J, Hitzel J
. Long noncoding RNA LISPR1 is required for S1P signaling and endothelial cell function. J Mol Cell Cardiol. 2018; 116:57-68.
DOI: 10.1016/j.yjmcc.2018.01.015.
View
9.
Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L
. Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021; 6(1):307.
PMC: 8403677.
DOI: 10.1038/s41392-021-00701-5.
View
10.
Brault V, MOORE R, Kutsch S, Ishibashi M, Rowitch D, McMahon A
. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 2001; 128(8):1253-64.
DOI: 10.1242/dev.128.8.1253.
View
11.
Braetz J, Becker A, Geissen M, Larena-Avellaneda A, Schrepfer S, Daum G
. Sphingosine-1-phosphate receptor 1 regulates neointimal growth in a humanized model for restenosis. J Vasc Surg. 2018; 68(6S):201S-207S.
DOI: 10.1016/j.jvs.2018.02.053.
View
12.
Williams H, Slater S, George S
. Suppression of neointima formation by targeting β-catenin/TCF pathway. Biosci Rep. 2016; 36(6).
PMC: 5146821.
DOI: 10.1042/BSR20160229.
View
13.
Sattler K, Elbasan S, Keul P, Elter-Schulz M, Bode C, Graler M
. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol. 2010; 105(6):821-32.
DOI: 10.1007/s00395-010-0112-5.
View
14.
Deutschman D, Carstens J, Klepper R, Smith W, Page M, Young T
. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J. 2003; 146(1):62-8.
DOI: 10.1016/S0002-8703(03)00118-2.
View
15.
Alexander M, Owens G
. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2011; 74:13-40.
DOI: 10.1146/annurev-physiol-012110-142315.
View
16.
Cartier A, Hla T
. Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. Science. 2019; 366(6463).
PMC: 7661103.
DOI: 10.1126/science.aar5551.
View
17.
Riascos-Bernal D, Chinnasamy P, Cao L, Dunaway C, Valenta T, Basler K
. β-Catenin C-terminal signals suppress p53 and are essential for artery formation. Nat Commun. 2016; 7:12389.
PMC: 4979065.
DOI: 10.1038/ncomms12389.
View
18.
Wendling O, Bornert J, Chambon P, Metzger D
. Efficient temporally-controlled targeted mutagenesis in smooth muscle cells of the adult mouse. Genesis. 2008; 47(1):14-8.
DOI: 10.1002/dvg.20448.
View
19.
Silva V, Micheletti T, Pimentel G, Katashima C, Lenhare L, Morari J
. Hypothalamic S1P/S1PR1 axis controls energy homeostasis. Nat Commun. 2014; 5:4859.
DOI: 10.1038/ncomms5859.
View
20.
Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn W, Hall J
. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res. 2002; 90(3):340-7.
DOI: 10.1161/hh0302.104466.
View